COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer
Authors:
- 1 September 2011
- journal article
- Published by Elsevier in Microvascular Research
- Vol. 82 (2) , 131-140
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancerAnnals of Oncology, 2009
- Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma SequenceCancer Research, 2006
- Targeting lymphangiogenesis to prevent tumour metastasisBritish Journal of Cancer, 2006
- Down-Regulation of Vascular Endothelial Cell Growth Factor-C Expression Using Small Interfering RNA Vectors in Mammary Tumors Inhibits Tumor Lymphangiogenesis and Spontaneous Metastasis and Enhances SurvivalCancer Research, 2005
- Effect of chronic intake of NSAIDs and cyclooxygenase 2—selective inhibitors on esophageal cancer incidenceClinical Gastroenterology and Hepatology, 2004
- COX-2: a target for prevention and treatment of esophageal cancerJournal of Surgical Research, 2004
- Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patientsAnnals of Oncology, 2002
- Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesisMolecular Carcinogenesis, 1999
- A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activationNature, 1996
- Aspirin and reduced risk of esophageal carcinomaCancer, 1995